INVESTOR RELATIONS

Events & Presentations

Our Clinical Development Programs

Our pipeline provides an overview of our late-stage clinical development programs and is updated quaterly.

Explore our pipeline
  • 14 PHASE II PROGRAMS
    • Advanced solid tumors
    • Biliary Tract Cancer
    • Colorectal Cancer
    • Cutaneous Squamous
      Cell Carcinoma
    • Cytomegalovirus Vaccine
    • Diabetes
    • HIV
    • Non-small Cell Lung Cancer
    • Melanoma
    • Ovarian Cancer
    • Pediatric Neurofibromatosis
    • Prostate Cancer
    • Respiratory Syncytial Virus
    • Schizophrenia
  • 20 PHASE III PROGRAMS
    • Bacterial Infection
    • Bacterial Pneumonia(2)
    • Breast Cancer
    • Colorectal Cancer
    • Cough
    • Ebola Vaccine
    • Endometrial Cancer
    • Esophageal Cancer
    • Gastric Cancer
    • Heart Failure
    • Herpes Zoster Vaccine
    • Liver Cancer
    • Mesothelioma
    • Nasopharyngeal Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Pneumoconjugate Vaccine
    • Renal Cancer
    • Small Cell Lung Cancer
  • 9 UNDER REVIEW
    • Breast Cancer
    • HIV (2)
    • Liver Cancer
    • Lung Cancer(2)
    • Melanoma
    • Merkel Cell Cancer
    • Pediatric Hexavalent Vaccine
  • Advanced solid tumors
  • Biliary Tract Cancer
  • Colorectal Cancer
  • Cutaneous Squamous
    Cell Carcinoma
  • Cytomegalovirus Vaccine
  • Diabetes
  • HIV
  • Non-small Cell Lung Cancer
  • Melanoma
  • Ovarian Cancer
  • Pediatric Neurofibromatosis
  • Prostate Cancer
  • Respiratory Syncytial Virus
  • Schizophrenia
  • Bacterial Infection
  • Bacterial Pneumonia(2)
  • Breast Cancer
  • Colorectal Cancer
  • Cough
  • Ebola Vaccine
  • Endometrial Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • Heart Failure
  • Herpes Zoster Vaccine
  • Liver Cancer
  • Mesothelioma
  • Nasopharyngeal Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Pneumoconjugate Vaccine
  • Renal Cancer
  • Small Cell Lung Cancer
  • Breast Cancer
  • HIV (2)
  • Liver Cancer
  • Lung Cancer(2)
  • Melanoma
  • Merkel Cell Cancer
  • Pediatric Hexavalent Vaccine
Data as of November 1, 2018